Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment

Mark E Beatty; Philippe Beutels; Martin I Meltzer; Donald S Shepard; Joachim Hombach; Raymond Hutubessy; Damien Dessis; Laurent Coudeville; Benoit Dervaux; Ole Wichmann; Harold S Margolis; Joel N Kuritsky

doi:10.4269/ajtmh.2011.10-0521

Back

Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment

Journal article

Open access

Peer reviewed

Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment

Mark E Beatty, Philippe Beutels, Martin I Meltzer, Donald S Shepard, Joachim Hombach, Raymond Hutubessy, Damien Dessis, Laurent Coudeville, Benoit Dervaux, Ole Wichmann, …

The American journal of tropical medicine and hygiene, Vol.84(3), pp.473-488

03/04/2011

DOI: https://doi.org/10.4269/ajtmh.2011.10-0521

PMCID: PMC3042827

PMID: 21363989

Abstract

Dengue vaccines are currently in development and policymakers need appropriate economic studies to determine their potential financial and public health impact. We searched five databases (PubMed, EMBASE, LILAC, EconLit, and WHOLIS) to identify health economics studies of dengue. Forty-three manuscripts were identified that provided primary data: 32 report economic burden of dengue and nine are comparative economic analyses assessing various interventions. The remaining two were a willingness-to-pay study and a policymaker survey. An expert panel reviewed the existing dengue economic literature and recommended future research to fill information gaps. Although dengue is an important vector-borne disease, the economic literature is relatively sparse and results have often been conflicting because of use of inconsistent assumptions. Health economic research specific to dengue is urgently needed to ensure informed decision making on the various options for controlling and preventing this disease.

Files and links (1)

url

https://doi.org/10.4269/ajtmh.2011.10-0521View

Published (Version of record) Open

Metrics

51 Record Views

See more details

Details

Title: Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment; BEATTY AND OTHERS
Creators: Mark E Beatty - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Philippe Beutels - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Martin I Meltzer - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Donald S Shepard - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Joachim Hombach - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Raymond Hutubessy - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Damien Dessis - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Laurent Coudeville - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Benoit Dervaux - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Ole Wichmann - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Harold S Margolis - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Joel N Kuritsky - Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea; Centre for Health Economics Research and Modeling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centers for Disease Control and Prevention, Atlanta, Georgia; Heller School, Brandeis University, Waltham, Massachusetts; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; GlaxoSmithKline Biologicals, Wavre, Belgium; Sanofi Pasteur, Lyon, France; Université Catholique de Lille, Lille, France
Publication Details: The American journal of tropical medicine and hygiene, Vol.84(3), pp.473-488
Publisher: The American Society of Tropical Medicine and Hygiene
Identifiers: 9923958177901921
Academic Unit: Heller School for Social Policy and Management
Language: English
Resource Type: Journal article

Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment

Abstract

Files and links (1)

Metrics

Details

Brandeis University Social media